Skip to content

Public FDA record

Z-2467-2018: T2100 Micro flex Drive Treadmill, powered Product Usage: Powered exercise equipment consist of powered

Recall record Z-2467-2018 for GE Medical Systems Ultrasound & Primary Care Diagnostics, LL. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2467-2018
Company in FDA record
GE Medical Systems Ultrasound & Primary Care Diagnostics, LL
FDA record creation date
Jul 16, 2018
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

A performance issue with customer owned spare parts, T2100 Microflex drive (2026182-002 or 2026182-004), was not addressed with a previous safety correction. If these parts were installed from customer owned stock on the T2100 Treadmill, uncontrolled walking belt motion during a stress exercise test could occur.

Source facts

Action
GE Healthcare sent an Urgent Medical Device Correction letter dated March 30, 2018 to customers. The letter identified the affected product, problem and actions to be taken. The letter stated that GE Healthcare will correct all affected products at no cost. Customers were asked to complete and return the attached "Customer Response" form via email to DCAR.30085@ge.com and a GE Healthcare representative will contact you to arrange for a correction if necessary. For questions contact GE Healthcare Service at 1-800-437-1171 or your local service Representative.
Initiated
2018-04-02
Root cause
Device Design
Terminated
2024-04-30
Distribution
Worldwide Distribution - US Nationwide in the states of AZ, CA, CO, FL, GA, ID, IL, IN, KS, LA, MA, MD, MI, MO, NC, NE, NJ, NV, NY, OH, OK, PA, SC, TN, TX, WA, WI. International distribution to Kenya DEMOCRATIC REPUBLIC OF CONGO, ALGERIA, ARGENTINA, Australia, AUSTRIA, AZERBAIJAN, BAHRAIN, BANGLADESH, BELGIUM, BHUTAN, BOLIVIA, BOSNIA-HERZEGOVINA, BRAZIL, BRUNEI, BULGARIA, BURMA(MYANMAR), CAMBODIA, CAMEROON, CANADA, CAYMAN ISLANDS, CHILE, CHINA, COLOMBIA, COSTA RICA, CROATIA, CYPRUS, CZECH REPUBLIC, DEMOCRATIC REPUBLIC OF CONGO, DOMINICAN REPUBLIC, ECUADOR, EGYPT, EL SALVADOR, ESTONIA, ETHIOPIA, GEORGIA, GERMANY, GREECE, GUAM, Hong Kong, INDIA, INDONESIA, IRAQ, IRELAND, ISRAEL, ITALY, JAMAICA, JORDAN, AZAKHSTAN, KENYA, KOREA, KUWAIT, LEBANON, LIBYA, MACEDONIA, ALAYSIA, MAURITIUS, MEXICO, MOLDOVA, MOROCCO, NAMIBIA, NEPAL, NEW CALEDONIA, NEW ZEALAND, Nigeria, PAKISTAN, PANAMA, PARAGUAY, PERU, PHILIPPINES, POLAND, PUERTO RICO, QATAR, REUNION, ROMANIA, RUSSIA, SERBIA--MONTENEGRO, SINGAPORE, SLOVAKIA, SLOVENIA, SOUTH AFRICA, SPAIN, SRI LANKA, SUDAN, SWITZERLAND, SYRIA, TAIWAN, TANZANIA, THAILAND, TRINIDAD AND TOBAGO, TUNISIA, TURKEY, UGANDA, UKRAINE, UNITED ARAB EMIRATES, URUGUAY, UZBEKISTAN, VENEZUELA, VIETNAM, Virgin Islands, YEMEN.
Recall number
Z-2467-2018
Recall status
Terminated
CDRH record ID
164767
FDA record created
2018-07-16
Recall event number
80165

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗